|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 31/192 | (2006.01) |
| (11) | Patento numeris | 2074992 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09156199.3 |
| Europos patento paraiškos padavimo data | 2006-04-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-07-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-05-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 669699 P | 2005-04-08 | US |
| (72) |
Ju, Tzuchi, R., US
Davila, Claudia, M., US
Engh, Kevin, R., US
Gao, Yi, US
Gustavson, Linda, E., US
Jayaraman, Shyamala, C., US
Leblond, David, US
Lee, Dennis, Y., US
|
| (73) |
ABBOTT LABORATORIES,
100 Abbott Park Road, Abbott Park, IL 60064-3500,
US
|
| (54) | Oral pharmaceutical formulations comprising salts of fenofibric acid |
| Oral pharmaceutical formulations comprising salts of fenofibric acid |